Article thumbnail

Acute Promyelocytic Leukemia Presenting with Central Nervous System Involvement: A Report of 2 Cases

By Misuk Ji, Hyun-Sook Chi, Seongsoo Jang, Chan-Jeoung Park, Jung-Hee Lee and Jong Jin Seo

Abstract

Central nervous system (CNS) involvement in acute promyelocytic leukemia (APL) is rare, and the presence of CNS symptoms at the time of diagnosis of APL is even rarer. We report 2 cases of APL presenting with CNS involvement. A 43-yr-old woman presented with easy bruising and stuporous mentality. Her complete blood count (CBC) revealed leukocytosis with increased blasts. Bone marrow (BM) analysis was carried out, and the diagnosis of APL was confirmed. This was done by cytogenetic analysis and demonstration of PML-RARα rearrangement by reverse transcriptase PCR in the BM cells. A lumbar puncture was performed to investigate the cause of her stuporous mentality, and her cerebrospinal fluid (CSF) analysis revealed 97% leukemic promyelocytes. Despite systemic and CNS therapy, she died due to septic shock by infection and rapid disease progression only 3 days after her admission. Another patient, a 3-yr-old girl, presented with easy bruising and epistaxis, and her CBC showed pancytopenia with increased blasts. BM studies confirmed APL. Quantitative PCR for PML-RARα in the BM cells revealed a PML-RARα/ABL ratio of 0.33 and CSF analysis revealed 9.5% leukemic promyelocytes (2 of 21 cells). She received induction chemotherapy and intrathecal therapy and achieved complete remission (CR) in the BM and CNS. She has been maintained in the CR status for the past 31 months. Thus, patients with APL must be evaluated for CNS involvement if any neurological symptoms are present at the time of diagnosis

Topics: Case Report
Publisher: The Korean Society for Laboratory Medicine
OAI identifier: oai:pubmedcentral.nih.gov:3111037
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1987). 43/F 0.9 17 ND ND Headache - IT cytarabine, TBI CR for 29 mo 5 2 1988 45/F 1.6 3 ND ND Headache, photophobia - TBI Relapsed after 45 mo 3*
  2. Acute promyelocytic leukaemia:a review.
  3. Central nervous system involvement at the time of presentation in acute promyelocytic leukemia.
  4. (1995). Characterization of acute promyelocytic leukemia cases with PMLRAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.
  5. Concurrent craniospinal radiotherapy and intrathecal chemotherapy in patient with acute promyelocytic leukemia second relapsed in central nervous system (CNS) following allogeneic stem cell transplantation.
  6. Detection of acute promyelocytic leukemia (APL) cells intermediately differentiated by all-trans retinoic acid in the cerebrospinal fluid: central nervous system involvement in APL.
  7. Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.
  8. Long-term remission of APL with a second allogeneic BMT after CNS relapse following HLA-identical allogeneic BMT.
  9. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
  10. Meningeal relapse in a patient with acute promyelocytic leukemia: a case report and review of the literature.